Kreon (Pancreas Powder)

Pancreas Powder contains lipase, amylase, and protease enzymes that are protected by a delayed‑release coating. The capsule dissolves in the duodenum, releasing the enzymes where they can act on ingested food, facilitating the breakdown and absorption of nutrients that would otherwise be poorly digested.

The dosage of Kreon is individualized and determined by the prescribing healthcare professional. The prescriber will consider the patient’s condition, severity of enzyme deficiency, and response to therapy when setting the appropriate number of capsules per meal or snack.

Safety data for Kreon in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Kreon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kreon, like other porcine‑derived enzyme preparations (e.g., Creon, Pancreaze), delivers lipase, amylase, and protease in a delayed‑release form. Differences may lie in enzyme potency per capsule, specific dosing recommendations, and excipient composition. Selection is typically based on physician preference, patient tolerance, and cost considerations.

Kreon capsules should be stored below 25 °C, in their original packaging, and protected from moisture. Keep the container tightly closed and avoid exposure to high humidity or direct sunlight to maintain enzyme stability.

Kreon is taken orally, usually with each main meal and snack that contains fat. The capsules should be swallowed whole with water and not crushed or chewed, as the coating protects the enzymes until they reach the small intestine.

Serious risks include allergic reactions such as rash, swelling, or anaphylaxis, respiratory distress like wheezing, and severe abdominal pain that could signal pancreatitis. Patients should seek immediate medical attention if any of these symptoms occur.

Kreon should not be used by individuals with a known hypersensitivity to porcine proteins or any of the capsule’s excipients. Patients with severe gastrointestinal disorders that affect absorption may also require alternative management under medical supervision.